Browse Drug Recalls
1,076 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 1,076 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 1,076 FDA drug recalls in CA.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Sep 21, 2023 | fentaNYL in dextrose 5%, 300 mcg/30 mL, (10 mcg/mL), 30 mL syringe, Rx only, ... | Lack of assurance of sterility: | Class II | Central Admixture Pharmacy Services Inc |
| Sep 21, 2023 | midazolam in dextrose 5%, 50 mg/50 mL, (1 mg/mL), 50 mL Syringe, Rx only, Cen... | Lack of assurance of sterility: | Class II | Central Admixture Pharmacy Services Inc |
| Sep 21, 2023 | HYDROmorphone in 0.9% sodium chloride, 15 mg/30 mL, (0.5 mg/mL), 30 mL Syring... | Lack of assurance of sterility: | Class II | Central Admixture Pharmacy Services Inc |
| Sep 21, 2023 | succinylcholine, 200 mg/10 mL, (20 mg/mL), 10 mL syringe, Rx only, CAPS, Inc.... | Lack of assurance of sterility: | Class II | Central Admixture Pharmacy Services Inc |
| Sep 21, 2023 | ketamine in 0.9% sodium chloride, 50 mg/5mL (10mg/mL), 5 mL syringe, Rx only,... | Lack of assurance of sterility: | Class II | Central Admixture Pharmacy Services Inc |
| Sep 21, 2023 | fentaNYL 1.5 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium chloride / Total... | Lack of assurance of sterility: | Class II | Central Admixture Pharmacy Services Inc |
| Sep 21, 2023 | fentaNYL, 250 mcg/5 mL, (50 mcg/mL), 5 mL Syringe, Rx only, Repackaged by CAP... | Lack of assurance of sterility: | Class II | Central Admixture Pharmacy Services Inc |
| Sep 21, 2023 | fentaNYL in 0.9% sodium chloride, 10 mcg/1 mL, (10 mcg/mL), 3 mL Syringe, Rx ... | Lack of assurance of sterility: | Class II | Central Admixture Pharmacy Services Inc |
| Sep 21, 2023 | fentaNYL in 0.9% sodium chloride, 100 mcg/10 mL, (10 mcg/mL), 10 mL Syringe, ... | Lack of assurance of sterility: | Class II | Central Admixture Pharmacy Services Inc |
| Sep 21, 2023 | PHENYLephrine in 0.9 sodium chloride, 400 mcg/10 mL, (40 mcg/mL), 10 mL Syrin... | Lack of assurance of sterility: | Class II | Central Admixture Pharmacy Services Inc |
| Sep 21, 2023 | PHENYLephrine in 0.9 sodium chloride, 800 mcg/10 mL, (80 mcg/mL), 10 mL Syrin... | Lack of assurance of sterility: | Class II | Central Admixture Pharmacy Services Inc |
| Sep 21, 2023 | fentaNYL in 0.9% sodium chloride, 10 mcg/1 mL, (10 mcg/mL), 3 mL syringe, Rx ... | Lack of assurance of sterility: | Class II | Central Admixture Pharmacy Services Inc |
| Sep 21, 2023 | fentaNYL 2 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium chloride / Total V... | Lack of assurance of sterility: | Class II | Central Admixture Pharmacy Services Inc |
| Sep 21, 2023 | fentaNYL, 1,250 mcg/25 mL, (50 mcg/mL), 30 mL Syringe, Rx only, Central Admix... | Lack of assurance of sterility: | Class II | Central Admixture Pharmacy Services Inc |
| Sep 21, 2023 | HYDROmorphone in 0.9% sodium chloride, 6 mg/30 mL, (0.2 mg/mL), 30 mL Syringe... | Lack of assurance of sterility: | Class II | Central Admixture Pharmacy Services Inc |
| Sep 21, 2023 | fentaNYL, 5,000 mcg/100 mL, (50 mcg/mL), 100 mL Bag, Rx only, Central Admixtu... | Lack of assurance of sterility: | Class II | Central Admixture Pharmacy Services Inc |
| Sep 21, 2023 | fentaNYL, 100 mcg/2 mL, (50 mcg/mL), 3 mL Syringe, Rx only, Repackaged by CAP... | Lack of assurance of sterility: | Class II | Central Admixture Pharmacy Services Inc |
| Aug 18, 2023 | Humanrace Suncare, Ozone Body Protection Cream, Broad Spectrum Sunscreen SPF ... | Subpotent Drug: Product does not contain SPF that is declared on the label. | Class II | HUMANRACE |
| Aug 18, 2023 | Humanrace Suncare, Ozone Face Protection Daily Moisturizer, Broad Spectrum Su... | Subpotent Drug: Product does not contain SPF that is declared on the label. | Class II | HUMANRACE |
| Jul 17, 2023 | fentaNYL in 0.9% sodium chloride, 500 mcg/50 mL, (10 mcg/mL), 50 mL Syringe, ... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | fentaNYL, 2500 mcg/50 mL, (50 mcg/mL), 50 mL Syringe, Rx only, Central Admixt... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | fentaNYL in 0.9% sodium chloride, 100 mcg/10 mL, (10 mcg/mL), 10 mL Syringe, ... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | ePHEDrine in 0.9% sodium chloride, 50 mg /5 mL, (10 mg/mL), 5 mL Syringe, Rx ... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | fentaNYL, 100 mcg/2 mL, (50 mcg/mL), 3 mL Syringe, Rx only, Central Admixture... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | fentaNYL in 0.9% sodium chloride, 10 mcg/1 mL, (10 mcg/mL), 3 mL syringe, Rx ... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | rocuronium, 50 mg /5 mL, (10 mg/mL), 5 mL Syringe, Rx only, Central Admixture... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | morphine in 0.9% sodium chloride, 30 mg/30 mL, (1 mg/mL), 30 mL Syringe, Rx o... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | ketamine in 0.9% sodium chloride, 50 mg/5mL (10mg/mL), 5 mL syringe, Rx only... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | PHENYLephrine in 0.9 sodium chloride, 400 mcg /10 mL, (40 mcg/mL), 10 mL Syri... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | HYDROmorphone in 0.9% sodium chloride, 6 mg/30 mL, (0.2 mg/mL), 30 mL Syringe... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | fentaNYL 2 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium chloride / Total V... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | fentaNYL, 250 mcg/5 mL, (50 mcg/mL), 5 mL Syringe, Rx only, Central Admixture... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | HYDROmorphone in Dextrose 5%, 0.5 mg/5 mL (0.1 mg/mL), 5 mL Syringe, Rx only,... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | HYDROmorphone in 0.9% sodium chloride, 30 mg/30 mL, (1 mg/mL), 30 mL Syringe,... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | fentaNYL 2 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium chloride, Total Vo... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | lidocaine 2%, 100 mg /5 mL, (20 mg/mL), 5 mL Syringe, Rx only, CAPS, Inc., 79... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | HYDROmorphone in 0.9% sodium chloride, 10 mg/50 mL, (0.2 mg/mL), 50 mL Syring... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | fentaNYL 1.5 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium chloride, Total ... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | fentaNYL in 0.9% sodium chloride, 2500 mcg/250 mL, (10 mcg/mL), 250 mL bag, R... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | HYDROmorphone in dextrose 5%, 3 mg/30 mL, (0.1 mg/mL), 30 mL Syringe, Rx only... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | PHENYLephrine in 0.9% sodium chloride, 1000 mcg/10 mL, (100 mcg/mL), 10 mL sy... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | vecuronium, 10 mg/10mL, (1 mg/mL), 10 mL syringe, Rx only, PARALYZING AGENT, ... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | fentaNYL in 0.9% sodium chloride, 1000 mcg/100 mL, (10 mcg/mL), 100 mL bag, R... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | fentaNYL in dextrose 5%, 300 mcg/30 mL, (10 mcg/mL), 30 mL syringe, Rx only, ... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | fentaNYL 2 mcg/mL and bupivacaine 0.0625% PF in 0.9% sodium chloride, Total V... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | morphine in 0.9% Sodium Chloride, 50 mg/50 mL (1mg/mL), 50 mL Syringe, Rx onl... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | fentaNYL in 0.9% sodium chloride, 10 mcg/1 mL, (10 mcg/mL), 3 mL Syringe, Rx ... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | morphine in 0.9% sodium chloride, 1 mg/1 mL, (1 mg/mL), 3 mL Syringe, Rx only... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | succinylcholine, 200 mg/10 mL, (20 mg/mL), 10 mL syringe, Rx only, CAPS, Inc.... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | PHENYLephrine in 0.9 sodium chloride, 800 mcg /10 mL, (80 mcg/mL), 10 mL Syri... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
Frequently Asked Questions
When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.